‘Profit over death’: millions of American diabetics struggle to afford insulin – The Guardian

Dan Hart lost his job as a bartender in Philadelphia, Pennsylvania, when the coronavirus pandemic hit in March, making it even harder to afford the insulin he requires as a type one diabetic.
Sign up for the Guardian Today US newsletter
Without health insurance for the past few years, Hart has relied on Walmart insulin at $26 a vial, while he continues trying to get health insurance through the state marketplace. His preferred insulin, out of pocket, would cost $1,500 a month.
His sister-in-law…

Click here to view the original article.